BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30807360)

  • 1. New debate of revascularization strategy of non-infarct-related artery lesions in patients with ST-segment elevation myocardial infarction and cardiogenic shock: decoding the CULPRIT-SHOCK trial, not enough to challenge the current guidelines.
    Song F; Wu Q; Chen XP
    Chin Med J (Engl); 2019 Mar; 132(5):613-615. PubMed ID: 30807360
    [No Abstract]   [Full Text] [Related]  

  • 2. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating the results of the CULPRIT-SHOCK trial in the 2017 ESC ST-elevation myocardial infarction guidelines: viewpoint of the task force.
    Ibanez B; Halvorsen S; Roffi M; Bueno H; Thiele H; Vranckx P; Neumann FJ; Windecker S; James S
    Eur Heart J; 2018 Dec; 39(48):4239-4242. PubMed ID: 29850788
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.
    Kosmidou I; McAndrew T; Redfors B; Embacher M; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CULPRIT-SHOCK study.
    Souza Júnior JM; Kulchetscki RM; Linhares Filho JPP; Lima EG; Serrano Junior CV
    Rev Assoc Med Bras (1992); 2018 Sep; 64(9):783-786. PubMed ID: 30672997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cardiogenic shock in the setting of ST-elevation myocardial infarction: controversies and future directions.
    Kohl LP; Jones WS
    Minerva Cardioangiol; 2015 Aug; 63(4):329-42. PubMed ID: 26005212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease.
    Di Pasquale G; Filippini E; Pavesi PC; Tortorici G; Casella G; Sangiorgio P
    Intern Emerg Med; 2016 Jun; 11(4):499-506. PubMed ID: 26951188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies and Challenges in the Management of ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock.
    Ko BS; Drakos SG; Welt FGP; Shah RU
    Interv Cardiol Clin; 2016 Oct; 5(4):541-549. PubMed ID: 28582002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonculprit Disease in Non-ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock.
    Iqbal MB
    JACC Cardiovasc Interv; 2021 May; 14(10):1079-1081. PubMed ID: 33933389
    [No Abstract]   [Full Text] [Related]  

  • 10. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
    Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathfinding to an optimal strategy of revascularization in primary coronary intervention in patients with multivessel disease: a network meta-analysis of randomized trials.
    Komócsi A; Kehl D; d'Ascenso F; DiNicolantonio J; Vorobcsuk A
    Curr Med Res Opin; 2017 Mar; 33(3):421-429. PubMed ID: 27848270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST-segment elevation myocardial infarction and refractory cardiogenic shock.
    Huang CC; Hsu JC; Wu YW; Ke SR; Huang JH; Chiu KM; Liao PC
    Int J Cardiol; 2018 Oct; 269():45-50. PubMed ID: 30077527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization strategies in cardiogenic shock after acute myocardial infarction.
    Desch S
    Curr Opin Crit Care; 2019 Aug; 25(4):379-383. PubMed ID: 31082824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention for nonculprit vessels in cardiogenic shock complicating ST-segment elevation acute myocardial infarction.
    Yang JH; Hahn JY; Song PS; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Kim YJ; Gwon HC
    Crit Care Med; 2014 Jan; 42(1):17-25. PubMed ID: 24105454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock due to acute pump failure.
    Kawaji T; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Mizoguchi T; Abe M; Takahashi M; Kimura T;
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):743-754. PubMed ID: 27708109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of complete revascularization using either angiography-guided or fractional flow reserve-guided drug-eluting stent implantation in non-culprit vessels in ST elevation myocardial infarction patients: insights from a study based on a systematic review and meta-analysis.
    Hideo-Kajita A; Garcia-Garcia HM; Kuku KO; Beyene SS; Azizi V; Meirovich YF; Melaku GD; Dheendsa A; Brathwaite EJ; Desale S; Soud M; Dan K; Ozaki Y; Waksman R; Lipinski M
    Int J Cardiovasc Imaging; 2018 Sep; 34(9):1349-1364. PubMed ID: 29779179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.
    Backhaus T; Fach A; Schmucker J; Fiehn E; Garstka D; Stehmeier J; Hambrecht R; Wienbergen H
    Clin Res Cardiol; 2018 May; 107(5):371-379. PubMed ID: 29230546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Regional ST-Segment-Elevation Myocardial Infarction Care: A Shock to the System.
    Ayalon N; Jacobs AK
    Circ Cardiovasc Interv; 2023 Jun; 16(6):e013177. PubMed ID: 37339238
    [No Abstract]   [Full Text] [Related]  

  • 20. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
    Babaev A; Frederick PD; Pasta DJ; Every N; Sichrovsky T; Hochman JS;
    JAMA; 2005 Jul; 294(4):448-54. PubMed ID: 16046651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.